JP2022533358A5 - - Google Patents
Info
- Publication number
- JP2022533358A5 JP2022533358A5 JP2021568406A JP2021568406A JP2022533358A5 JP 2022533358 A5 JP2022533358 A5 JP 2022533358A5 JP 2021568406 A JP2021568406 A JP 2021568406A JP 2021568406 A JP2021568406 A JP 2021568406A JP 2022533358 A5 JP2022533358 A5 JP 2022533358A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense oligonucleotide
- nucleotide
- rage
- premrna
- exon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025061149A JP2025106369A (ja) | 2019-05-14 | 2025-04-02 | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019901641 | 2019-05-14 | ||
| AU2019901641A AU2019901641A0 (en) | 2019-05-14 | Modulators and Modulation of the Receptor for Advanced Glycation End-Products RNA | |
| AU2019902095A AU2019902095A0 (en) | 2019-06-17 | Modulators and Modulation of the Receptor for Advanced Glycation End-Products RNA | |
| AU2019902095 | 2019-06-17 | ||
| AU2019902772A AU2019902772A0 (en) | 2019-08-02 | Modulators and Modulation of the Receptor for Advanced Glycation End-Products RNA | |
| AU2019902772 | 2019-08-02 | ||
| AU2019903900 | 2019-10-16 | ||
| AU2019903900A AU2019903900A0 (en) | 2019-10-16 | Modulators and Modulation of the Receptor for Advanced Glycation End-Products RNA | |
| PCT/AU2020/050449 WO2020227758A1 (en) | 2019-05-14 | 2020-05-07 | Modulators and modulation of the receptor for advanced glycation end-products rna |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061149A Division JP2025106369A (ja) | 2019-05-14 | 2025-04-02 | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533358A JP2022533358A (ja) | 2022-07-22 |
| JP2022533358A5 true JP2022533358A5 (enExample) | 2023-08-15 |
Family
ID=73290056
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568406A Pending JP2022533358A (ja) | 2019-05-14 | 2020-05-07 | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
| JP2025061149A Pending JP2025106369A (ja) | 2019-05-14 | 2025-04-02 | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061149A Pending JP2025106369A (ja) | 2019-05-14 | 2025-04-02 | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11441148B2 (enExample) |
| EP (1) | EP3969590A4 (enExample) |
| JP (2) | JP2022533358A (enExample) |
| KR (1) | KR20220009971A (enExample) |
| CN (1) | CN114127288A (enExample) |
| AU (2) | AU2020276337B2 (enExample) |
| BR (1) | BR112021022714A2 (enExample) |
| CA (1) | CA3140209A1 (enExample) |
| IL (1) | IL288040A (enExample) |
| MX (1) | MX2021013858A (enExample) |
| SG (1) | SG11202112144RA (enExample) |
| WO (1) | WO2020227758A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022533358A (ja) | 2019-05-14 | 2022-07-22 | モナシュ ユニバーシティ | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
| WO2024229505A1 (en) * | 2023-05-05 | 2024-11-14 | RAGE Biotech Pty Ltd | Administration of oligonucleotides |
| KR20260028678A (ko) * | 2023-05-05 | 2026-03-04 | 레이지 바이오텍 피티와이 리미티드 | 스플라이싱 모니터링 방법 |
| WO2024239040A1 (en) * | 2023-05-19 | 2024-11-28 | RAGE Biotech Pty Ltd | Methods of minimising the effects of smoke exposure |
| WO2024239039A1 (en) * | 2023-05-19 | 2024-11-28 | RAGE Biotech Pty Ltd | Methods of treating pulmonary fibrosis |
| CN119709736A (zh) * | 2023-09-27 | 2025-03-28 | 长春金赛药业有限责任公司 | 一种新的siRNA、包含其的组合物及用途 |
| WO2025076595A1 (en) * | 2023-10-12 | 2025-04-17 | RAGE Biotech Pty Ltd | Rnai agents targeting rage |
| WO2025222258A1 (en) * | 2024-04-24 | 2025-10-30 | RAGE Biotech Pty Ltd | Methods of treating or preventing obstructive pulmonary disease |
| WO2025236048A1 (en) * | 2024-05-17 | 2025-11-20 | RAGE Biotech Pty Ltd | Methods of treating the effects of smoke |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| US20020123476A1 (en) | 1991-03-19 | 2002-09-05 | Emanuele R. Martin | Therapeutic delivery compositions and methods of use thereof |
| US6806084B1 (en) | 1992-06-04 | 2004-10-19 | The Regents Of The University Of California | Methods for compositions for in vivo gene delivery |
| WO1997022371A1 (en) | 1995-12-18 | 1997-06-26 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
| CA2294988C (en) | 1997-07-01 | 2015-11-24 | Isis Pharmaceuticals Inc. | Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| EP1156812A4 (en) | 1999-02-23 | 2004-09-29 | Isis Pharmaceuticals Inc | MULTIPARTICULAR FORMULATION |
| US6287860B1 (en) | 2000-01-20 | 2001-09-11 | Isis Pharmaceuticals, Inc. | Antisense inhibition of MEKK2 expression |
| JP3837494B2 (ja) | 2001-03-19 | 2006-10-25 | 国立大学法人金沢大学 | 可溶型ｒａｇｅタンパク質 |
| US7026121B1 (en) * | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) * | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| US6965025B2 (en) | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
| JP2008539698A (ja) * | 2005-04-29 | 2008-11-20 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 転写後レベルでの核酸発現調節のための方法および組成物 |
| US20100016215A1 (en) | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| JP2010233542A (ja) * | 2009-03-31 | 2010-10-21 | Kanazawa Univ | Ｒａｇｅ遺伝子の２種類のスプライシングバリアントを区別して増幅可能なプライマーセット及びプローブ |
| US20100303776A1 (en) * | 2009-04-16 | 2010-12-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for regulated expression of multiple nucleic acids |
| US9315298B2 (en) | 2011-08-25 | 2016-04-19 | Db Equipment As | Accessory bag having reinforced sidewalls and variable length |
| EP3793352A4 (en) * | 2018-05-17 | 2022-04-13 | Lifesplice Pharma LLC | RECEPTOR-TARGETING SPLICING MODULATING OLIGONUCLEOTIDES FOR ADVANCED GLYCATION END PRODUCTS AND METHODS OF USE |
| JP2022533358A (ja) | 2019-05-14 | 2022-07-22 | モナシュ ユニバーシティ | 終末糖化産物受容体ｒｎａのモジュレーター及び調節 |
-
2020
- 2020-05-07 JP JP2021568406A patent/JP2022533358A/ja active Pending
- 2020-05-07 WO PCT/AU2020/050449 patent/WO2020227758A1/en not_active Ceased
- 2020-05-07 EP EP20806464.2A patent/EP3969590A4/en active Pending
- 2020-05-07 CN CN202080044288.6A patent/CN114127288A/zh active Pending
- 2020-05-07 KR KR1020217039458A patent/KR20220009971A/ko active Pending
- 2020-05-07 SG SG11202112144RA patent/SG11202112144RA/en unknown
- 2020-05-07 BR BR112021022714A patent/BR112021022714A2/pt unknown
- 2020-05-07 AU AU2020276337A patent/AU2020276337B2/en active Active
- 2020-05-07 CA CA3140209A patent/CA3140209A1/en active Pending
- 2020-05-07 MX MX2021013858A patent/MX2021013858A/es unknown
-
2021
- 2021-08-25 US US17/411,932 patent/US11441148B2/en active Active
- 2021-11-11 IL IL288040A patent/IL288040A/en unknown
-
2022
- 2022-09-07 US US17/930,364 patent/US11674143B2/en active Active
-
2023
- 2023-05-01 US US18/310,289 patent/US12565656B2/en active Active
-
2025
- 2025-04-02 JP JP2025061149A patent/JP2025106369A/ja active Pending
- 2025-08-29 AU AU2025223886A patent/AU2025223886A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022533358A5 (enExample) | ||
| JP7420679B2 (ja) | 状態および疾患の処置のためのアンチセンスオリゴマー | |
| RU2566724C9 (ru) | Композиции и способы модуляции smn2 сплайсинга у субъекта | |
| JP7049262B2 (ja) | 結合組織成長因子を標的とするｒｎａ複合体を用いた特発性肺胞線維症の治療 | |
| JP2015518710A (ja) | ヘモグロビン遺伝子ファミリー発現を調節するための組成物及び方法 | |
| JP2015523855A (ja) | Ａｐｏａ１及びａｂｃａ１発現を調節するための組成物及び方法 | |
| US20150232847A1 (en) | Targeting oligonucleotides and related methods for modulating fxn rna | |
| JP2015518712A (ja) | Ｍｅｃｐ２発現を調節するための組成物及び方法 | |
| JP2015523853A (ja) | Ａｔｐ２ａ２発現を調節するための組成物及び方法 | |
| JP2015518713A (ja) | Ｕｔｒｎ発現を調節するための組成物及び方法 | |
| JP2015523854A (ja) | Ｓｍｎ遺伝子ファミリー発現を調節するための組成物及び方法 | |
| JP2015518711A (ja) | Ｂｄｎｆ発現を調節するための組成物及び方法 | |
| JP2016531570A (ja) | ユークロマチン領域を標的とするオリゴヌクレオチド | |
| JP2015519057A (ja) | Ｐｔｅｎ発現を調節するための組成物及び方法 | |
| JP2024530169A (ja) | 方法 | |
| WO2025090567A1 (en) | LOW DOSE siRNA TREATMENTS OF HUNTINGTON'S DISEASE | |
| WO2021157730A1 (ja) | 核酸医薬とその使用 | |
| JPH0851985A (ja) | イソプレニルタンパク質トランスフェラーゼの発現を抑制するオリゴヌクレオチド、それを含有する治療剤組成物及び該組成物の使用方法 | |
| KR101783444B1 (ko) | miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법 | |
| CN111394356B (zh) | 一种内源性长链非编码rna mrak049966及其应用 | |
| JP2025501269A (ja) | アンチセンスオリゴヌクレオチド及びその使用 | |
| CN114887063A (zh) | Pacsin1在抑制瑞芬太尼诱发的痛觉过敏中的应用 | |
| RU2021134071A (ru) | Модуляторы и модуляция рнк рецептора конечных продуктов глубокого гликирования | |
| EP4608980A1 (en) | Compositions and methods for anti-sense oligonucleotide (aso) treatment of huntington's disease | |
| JP2025507279A5 (enExample) |